| View |
DRP-3644_PIL_01.pdf
|
DRP-3644
|
PARACETAMOL
|
UNIGESIC
|
250mg/5mL
|
Oral Solution
|
ANALGESIC/ANTIPYRETIC
|
St. Martin Pharm Lab Co.
|
Philippines
|
Renewal
|
19 August 2024
|
11 August 2029
|
| View |
DR-XY18187_PIL_01.pdf
|
DR-XY18187
|
CARBOCISTEINE
|
GUIAMAR
|
100 mg/5mL
|
Syrup
|
MUCOLYTIC
|
St. Martin Pharm Lab Co.
|
Philippines
|
Renewal
|
13 October 2024
|
27 December 2029
|
| View |
DRP-3697_PI_01_NO RX SYMBOL.pdf
|
DRP-3697
|
DILOXANIDE FUROATE
|
DILFUR
|
125 mg/ 5 mL
|
Suspension
|
AMEBICIDE
|
St. Martin Pharm Lab Co.
|
Philippines
|
Renewal
|
31 May 2024
|
06 April 2029
|
| View |
DR-X9620_PIL_01.pdf
|
DR-X9620
|
GUAIFENESIN
|
GUAIACOF
|
100 mg/5mL
|
Oral Solution
|
EXPECTORANT
|
St. Martin Pharm Lab Co.
|
Philippines
|
Renewal
|
12 October 2024
|
27 December 2029
|
| View |
|
DRP-12448
|
Omeprazole
|
Prazome
|
20 mg
|
Delayed Release Capsule
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
09 August 2022
|
09 August 2027
|
| View |
|
DRP-12446
|
Metoprolol Tartrate
|
None
|
50 mg
|
Tablet
|
Selective Beta-Blocking Agent
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
09 August 2022
|
09 August 2027
|
| View |
|
DRP-12447
|
Metoprolol Tartrate
|
Meobloc 50
|
50 mg
|
Tablet
|
-
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
09 August 2022
|
09 August 2027
|
| View |
|
DR-XY47992
|
Zinc
|
I-Zn
|
20 mg (equivalent to 55 mg Zinc Sulfate
Monohydrate) / 5mL
|
Syrup (Tutti-Frutti Flavor)
|
Mineral
|
Izmed Laboratories, Corp.
|
Philippines
|
Initial (OTC)
|
02 May 2022
|
02 May 2027
|
| View |
DRP-12441_PIL_01.pdf
|
DRP-12441
|
Ascorbic Acid + Colecalciferol + Zinc
|
Immuneplus
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/
1000 IU/25 mg (equivalent to 68.62 mg Zinc Sulfate
Monohydrate)
|
Capsule
|
Vitamins + Mineral
|
San Marino Laboratories Corporation
|
Philippines
|
Initial (OTC)
|
09 August 2022
|
09 August 2027
|
| View |
|
DRP-11798
|
Betahistine Hydrochloride
|
Vertset
|
16 mg
|
Tablet
|
Antivertigo
|
Globela Pharma Private Limited
|
India
|
Initial
|
29 April 2022
|
29 April 2027
|
| View |
|
DRP-12440
|
Ascorbic Acid
|
None
|
1000 mg
|
Tablet
|
Vitamins
|
SLS Co., Ltd.
|
Korea
|
Initial (OTC)
|
09 August 2022
|
09 August 2027
|
| View |
|
DRP-12437
|
Ascorbic Acid
|
Haruvita
|
1000 mg
|
Tablet
|
Vitamins
|
SLS Co., Ltd.
|
Korea
|
Initial (OTC)
|
09 August 2022
|
09 August 2027
|
| View |
|
DRP-12444
|
Paclitaxel
|
Taxaica-300
|
6 mg/mL (300 mg/50 mL)
|
Concentrate Solution for
Injection for I.V. Infusion
|
Antineoplastic
|
ADMAC Lifesciences
|
India
|
Initial
|
09 August 2022
|
09 August 2027
|
| View |
|
DR-XY48263
|
Multivitamins + Amino Acids + Iron + Guarana
|
Stressaide
|
Formulation Each Film-Coated Tablet contains: Retinyl Acetate (Vitamin A) dl-alpha Tocopheryl Acetate (Vitamin E) Thiamine Mononitrate (Vitamin B1) Riboflavin (Vitamin B2) Pyridoxine Hydrochloride (Vitamin B6) Cyanocobalamin (Vitamin B12) Niacinamide (Vitamin B3)
1500 IU 5 IU 5 mg 3 mg 1.5 mg 5 mcg 20 mg
Calcium Pantothenate (Vitamin B5) Iron (as Carbonyl) (Ferronyl Iron) Methionine (as Racemethionine) Lysine (as Hydrochloride) Debittered Brewer's Yeast Guarana
10 mg 8 mg 5 mg 2.25 mg 25 mg 100 mg
|
Film-Coated Tablet
|
Vitamins / Minerals
|
Amherst Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
09 August 2022
|
09 August 2027
|
| View |
|
DR-XY48265
|
Fingolimod (as hydrochloride)
|
Finmod
|
500 mcg
|
Capsule
|
Selective Immunosuppressant
|
Hetero Labs Limited
|
India
|
Initial
|
09 August 2022
|
09 August 2027
|
| View |
|
DR-XY47985
|
Metronidazole
|
Siti-zole
|
5 mg/mL (500 mg/ 100 mL)
|
Solution for I.V. Infusion.
|
Antibacterial/ Antiprotozoal (Nitroimidazole Derivative)
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd
|
China
|
Initial (Correction)
|
14 May 2024
|
28 April 2027
|
| View |
|
DR-XY48264
|
Oxaliplatin
|
Oxalibil
|
5 mg/ mL (100 mg/20 mL)
|
Concentrate for Solution for
Intravenous (IV) Infusion
|
Antineoplastic Agent (Platinum Compound)
|
SP Accure Labs Pvt. Ltd.
|
India
|
Initial
|
09 August 2022
|
09 August 2027
|
| View |
|
DRP-12580
|
Cefuroxime (as Axetil)
|
Hiroxime-250
|
250 mg/5 mL
|
Powder For Oral Suspension
|
-
|
Hiral Labs Limited
|
India
|
Initial
|
07 September 2022
|
07 September 2027
|
| View |
|
BR-1419
|
Tildrakizumab
|
Ilumya
|
100 mg/mL
|
Solution for Injection (S.C.)
|
Interleukin Inhibitor
|
Vetter Pharma-Fertigung GmbH & Co. KG
|
Germany
|
Monitored Release (Reconstruction)
|
24 May 2024
|
13 September 2027
|
| View |
DR-XY48345_PI_01.pdf
|
DR-XY48345
|
Zanubrutinib
|
Brukinsa
|
80 mg
|
Capsule
|
Bruton's Tyrosine Kinase (BTK) Inhibitor
|
Catalent CTS, LLC
|
United States of America
|
Monitored Release
|
08 September 2022
|
08 September 2027
|